Inflammation, high density lipoprotein and endothelium.

Area of Science:

• Cardiovascular Science
• Lipid Metabolism
• Oxidative Stress Biology

Background:

• High density lipoprotein (HDL) is crucial for cardiovascular health, mediating anti-inflammatory effects and reverse cholesterol transport.
• HDL-cholesterol levels are inversely linked to cardiovascular event risk.
• Apolipoprotein A-I (apo A-I), the primary HDL component, facilitates cholesterol efflux via the ABCA1 transporter.

Purpose of the Study:

• To explore the dual roles of HDL in inflammation modulation and reverse cholesterol transport.
• To investigate the impact of oxidative stress on HDL functionality and its protein components.
• To evaluate the potential of apo A-I mimetic peptides in preclinical models for improving HDL function and reducing atherosclerosis.

Main Methods:

• Analysis of HDL's anti-inflammatory and cholesterol transport functions.
• Assessment of oxidative damage effects on apo A-I and other HDL proteins.
• Preclinical evaluation of apo A-I mimetic peptides in models of atherosclerosis and endothelial dysfunction.

Main Results:

• Oxidative modification can render apo A-I less effective in promoting cholesterol efflux.
• Dysfunctional HDL, resulting from protein modification, can adopt pro-inflammatory properties.
• Apo A-I mimetic peptides demonstrated efficacy in preclinical models, improving HDL function and reducing atherosclerosis without affecting HDL-cholesterol levels.

Conclusions:

• HDL's protective functions against cardiovascular events are vulnerable to oxidative damage.
• Strategies to restore or mimic HDL functionality, such as using apo A-I peptides, hold promise for treating atherosclerosis.
• Maintaining endothelial function through antioxidant and anti-inflammatory systems, including HDL, is vital for vascular health.